Skip to content

Dr. Rustandi

Active
Private limited companyfounded 20205 yrs activeTervuursevest 254, 3000 Leuven, BelgiumKBO/BCE: BE 0754.894.481
Summary

The computed 12-month bankruptcy probability of Dr. Rustandi is 2.0% (moderate). The 2025 annual accounts show equity of €125k and a net result of €117k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
80 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+61
Growth32▼-26
Track record94
Bankruptcy probability, 12 months
2.0% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 6.59 against 1.16 in 2024; short-term debt: 14.6% and cash: 25% of total assets), and 14.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 5 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
85.4%
Return on assets
80.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
30 d early
2024
7 d early
2023
30 d late
2022
31 d early
2021
31 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€125k▲ 281%
2024 · €33k
2021: €171k 2022: €289k 2023: €415k 2024: €33k
2021 → 2025
Total assets
€146k▼ 36.4%
2024 · €229k
2021: €178k 2022: €300k 2023: €434k 2024: €229k
2021 → 2025
Net result
€117k▼ 35.7%
2024 · €182k
2021: €168k 2022: €118k 2023: €126k 2024: €182k
2021 → 2025
Working capital
€119k▲ 267%
2024 · €32k
2021: €170k 2022: €288k 2023: €417k 2024: €32k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€171k-€289k▲ 68.7%€415k▲ 43.6%€33k▼ 92.1%€125k▲ 281%
Operating result€218k-€151k▼ 30.8%€162k▲ 7.4%€230k▲ 42.2%€143k▼ 38.0%
Net result€168k-€118k▼ 30.0%€126k▲ 7.1%€182k▲ 44.3%€117k▼ 35.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2021: €218k€218kNet result 2021: €168k€168kOperating result 2022: €151k€151kNet result 2022: €118k€118kOperating result 2023: €162k€162kNet result 2023: €126k€126kOperating result 2024: €230k€230kNet result 2024: €182k€182kOperating result 2025: €143k€143kNet result 2025: €117k€117k20212022202320242025€0€100k€200kOperating result 2023: €162k€162kNet result 2023: €126k€126kOperating result 2024: €230k€230kNet result 2024: €182k€182kOperating result 2025: €143k€143kNet result 2025: €117k€117k202320242025
The operating result falls in 2025; 2025 is 38% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €146k
Fixed assets €5k
Current assets €140k
Equity and liabilities €146k
Equity €125k ▲ 281%
Debt €21k ▼ 89.2%
Debt's share of the balance-sheet total falls from 85.8% to 14.6%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€148k
2024 · €230k
Cash flow
€122k
2024 · €182k
Current ratio
6.59
2024 · 1.16
Debt to equity
0.17
2024 · 6.02
ROE
93.8%
2024 · 556.1%
ROA
80.1%
2024 · 79.2%
Interest coverage
304.34
2024 · 1908.98
Debt ≤ 1 year
€21k
2024 · €197k
Income taxes
€33k
2024 · €54k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet Code20242025
Assets
Total assets20/58€229k€146k
Formation expenses20€261€0
Fixed assets21/28-€5k
Tangible fixed assets22/27-€5k
Furniture and vehicles24-€5k
Current assets29/58€229k€140k
Amounts receivable within one year40/41€39k€18k
Trade receivables40€39k€0
Other amounts receivable41-€18k
Current investments50/53€32k€62k
Cash at bank and in hand54/58€158k€36k
Deferred charges and accrued income490/1-€24k
Equity and liabilities
Total equity and liabilities10/49€229k€146k
Equity10/15€33k€125k
Contributions10/11€3k€3k=
Reserves13€30k€122k
Distributable reserves133€30k€122k
Profit (loss) carried forward14-€0
Amounts payable17/49€197k€21k
Amounts payable within one year42/48€197k€21k
Trade debts44-€2k
Suppliers440/4-€2k
Taxes, remuneration and social security45€5k€13k
Taxes450/3€5k€6k
Remuneration and social security454/9-€7k
Other amounts payable47/48€191k€7k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€260€6k
Other operating charges640/8€451€640
Gross operating margin9900€231k€149k
Operating profit (loss)9901€230k€143k
Financial income75/76B€6k€7k
Recurring financial income75€6k€1k
Non-recurring financial income76B-€6k
Financial charges65/66B€121€487
Recurring financial charges65€121€487
Profit (loss) for the period before taxes9903€236k€149k
Income taxes67/77€54k€33k
Profit (loss) for the period9904€182k€117k
Profit (loss) for the period to be appropriated9905€182k€117k
Appropriation of the result
Profit (loss) to be appropriated9906€182k€117k
Transfer from equity791/2€382k€25k
Transfer to equity691/2-€117k
To other reserves6921-€117k
Profit to be distributed694/7€564k€25k
Return on contributions (dividend)694€564k€25k

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
01-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Weakest financial yearnet €117k ▼35.7%
Net result drops to €117k, the lowest in the series.
31-12
Financial Liquidity times 6current ratio 6.59
Current ratio from 1.16 to 6.59; short-term debt falls from €197k to €21k.
31-12
Financial Equity above €100kEq €125k ▲281%
5 profitable years in a row build equity to €125k.
24-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2021net €182k ▲44.3%
Operating result €230k, net result €182k, both a record.
30-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
30-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Equity above €200kEq €289k ▲68.7%
2 profitable years in a row build equity to €289k.
30-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2020
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Tervuursevest 2543000 Leuven
Ground area
914 m²
Building footprint
851 m²
Volume, LiDAR
11,296 m³
Parcel 24504E0421/00H003, Flanders · tallest building 28.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Rustandi
Tervuursevest 254, 3000 LeuvenSpecialist medical practice
since 20202.307.879.428
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24504E0421/00H003 Flanders 914 m² 1 · 851 m² 28.7 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded25-09-2020
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.